RhumbLine Advisers’s Crescent Biopharma CBIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10	Closed	-$294	–	4250
2024 Q2	$294	Hold	10	–	–	﹤0.01%	4309
2024 Q1	$3.13K	Hold	10	–	–	﹤0.01%	4041
2023 Q4	$2.46K	Hold	10	–	–	﹤0.01%	4077
2023 Q3	$1.57K	Hold	10	–	–	﹤0.01%	4139
2023 Q2	$1.82K	Buy	+10	New	+$1.68K	﹤0.01%	4227
2021 Q2	–	Sell	-607	Closed	-$183K	–	3039
2021 Q1	$183K	Hold	607	–	–	﹤0.01%	2852
2020 Q4	$228K	Buy	607 +79	+15%	+$27.7K	﹤0.01%	2782
2020 Q3	$162K	Sell	528 -61	-10%	-$23.3K	﹤0.01%	2748
2020 Q2	$221K	Buy	589 +147	+33%	+$41.6K	﹤0.01%	2725
2020 Q1	$101K	Hold	442	–	–	﹤0.01%	2777
2019 Q4	$234K	Buy	442 +3	+0.7%	+$1.62K	﹤0.01%	2696
2019 Q3	$189K	Sell	439 -4	-0.9%	-$2.57K	﹤0.01%	2764
2019 Q2	$528K	Buy	443 +10	+2%	+$12K	﹤0.01%	2337
2019 Q1	$540K	Sell	433 -13	-3%	-$14.9K	﹤0.01%	2301
2018 Q4	$422K	Buy	446 +144	+48%	+$173K	﹤0.01%	2377
2018 Q3	$435K	Sell	302 -18	-6%	-$27.2K	﹤0.01%	2332
2018 Q2	$516K	Buy	+320	New	+$550K	﹤0.01%	2301